InspireMD, Inc. (NSPR) |
| 0.85 -0.039 (-4.35%) 08-28 16:00 |
| Open: | 0.8612 |
| High: | 0.8961 |
| Low: | 0.8436 |
| Volume: | 74,225 |
| Market Cap: | 40(M) |
| PE Ratio: | -1.33 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.19 |
| Resistance 1: | 1.02 |
| Pivot price: | 0.88 |
| Support 1: | 0.79 |
| Support 2: | 0.65 |
| 52w High: | 2.57 |
| 52w Low: | 0.63 |
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
| EPS | -0.610 |
| Book Value | 1.270 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.065 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -411.36 |
| Return on Assets (ttm) | -68.5 |
| Return on Equity (ttm) | -142.6 |
Thu, 27 Aug 2026
InspireMD Inc. (NSPR) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Thu, 20 Aug 2026
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Mon, 17 Aug 2026
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
Mon, 17 Aug 2026
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
Thu, 13 Aug 2026
InspireMD (NSPR.US) is scheduled to release its financial report on August 17. - Moomoo
Mon, 10 Aug 2026
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |